Tuesday 8/25 Insider Buying Report: HRMY, CBFV

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

Bargain hunters are wise to pay careful attention to insider buying, because although there are many various reasons for an insider to sell a stock, presumably the only reason they would use their hard-earned cash to make a purchase, is that they expect to make money.

Today we look at two noteworthy recent insider buys.

At Harmony Biosciences Holdings, a filing with the SEC revealed that on Monday, Director Jack Nielsen bought 37,957 shares of HRMY, at a cost of $27.58 each, for a total investment of $1.05M.

So far Nielsen is in the green, up about 23.3% on their purchase based on today's trading high of $34.00.

Harmony Biosciences Holdings is trading off about 0.4% on the day Tuesday.

And on Friday, Director John J.

Lacarte bought $428,874 worth of CB Financial Services, buying 23,500 shares at a cost of $18.25 each.

Before this latest buy, Lacarte bought CBFV on 7 other occasions during the past twelve months, for a total investment of $107,532 at an average of $24.37 per share.

CB Financial Services is trading up about 2.2% on the day Tuesday.

So far Lacarte is in the green, up about 3.3% on their buy based on today's trading high of $18.85.